Predictive validity of SOFA-2: analytical and contextual considerations - Takeaways - MDSpire

Predictive validity of SOFA-2: analytical and contextual considerations

Share

1

Helleberg et al. conducted the first external validation of SOFA-2 against 30-day mortality in nearly 30,000 ICU admissions.
2

SOFA-2 showed a small discriminative advantage on ICU day 1, but the net reclassification improvement was minimal at 0.09.
3

The predictive validity of SOFA-2 varies significantly by case-mix, with trauma patients showing higher AUROC than sepsis patients.
4

SOFA-2-specific components were not manually validated, raising concerns about potential errors in reclassification patterns.
5

The advantages of SOFA-2 are primarily limited to ICU day 1 and may be inflated by unvalidated component extraction.